Delivery Order SPE2DB22D9206-SPE2DB25FV5ET
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $52,649.48 by the Defense Logistics Agency on September 5, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic commonly used for surgical pain management. The delivery order is not set-aside designated and carries an ultimate completion date of September 26,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30,127.56 by the Defense Logistics Agency on August 20, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine formulation used for post-operative pain management. The award carries no set-aside designation, and performance is scheduled for completion by September 11, 2025, with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,655.32 by the Defense Logistics Agency on August 28, 2025. The contract covers the delivery of Exparel 133 mg/10 ml vials, a liposomal bupivacaine product used for local anesthesia and postoperative pain management. Performance of this delivery order is scheduled for completion by September 19, 2025, with the place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $2,510.63 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Exparel 266 mg/20 ml vials. This delivery order is issued without a set-aside designation and carries an ultimate completion date of September 17, 2025. The contract represents a direct pharmaceutical supply fulfillment for DLA's medical logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,185.32 by the Defense Logistics Agency (DLA) on September 12, 2025. The order covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine product used for local anesthesia and pain management in surgical and medical applications. This is a firm fixed-price delivery order with no set-aside designation, reflecting the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on September 3, 2025. The contract covers the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical settings, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and will be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22.6K by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Exparel 133 mg/10 mL vials. This firm fixed-price delivery order, with an ultimate completion date of June 24, 2025, represents a direct fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract...
- SPE2DB22D9206Indefinite Delivery Contract
- SPE2DB22D9206-SPE2DB25FV5ETDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,053.55 by the Defense Logistics Agency (DLA) on September 24, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. The delivery order is set to be completed by October 16, 2025, with performance taking place at the contractor's facility in Park Ridge, Illinois. This award was made without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion comprehensive pharmaceutical supply agreement valid through November 2026. The IDC enables the Defense Logistics Agency to issue multiple firm fixed-price delivery orders for a broad range of pharmaceutical items and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while providing critical medications and medical supplies to Department of Defense healthcare sites across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 9/24/25 |